+++ 808.222 Press releases +++ 33.644 Newsrooms +++ 6.000 Media +++


BIOTRONIK Pacemakers that Automatically Adapt to MRI Environments Get CE Approval

, Medical Technology

BIOTRONIK has announced CE approval for its new Edora pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps). Edora devices feature...

BIOTRONIK meldet CE-Zulassung für neue Herzschrittmacher-Serie

, Medical Technology

BIOTRONIK setzt Maßstäbe mit der neuen Edora Herzschrittmacher- und CRT-P Serie. Die Geräte verfügen sowohl über die BIOTRONIK ProMRI®-Technologie...

Neues bioresorbierbares Gefäßgerüst aus Magnesium erhält CE-Zulassung

, Medical Technology

BIOTRONIK gab heute im Rahmen des „Great Minds Expertentreffens“ in Berlin die CE-Kennzeichnung und europäische Markteinführung von Magmaris...

BIOTRONIK Launches Smallest MR Conditional Pacing Lead Available in the United States

, Medical Technology

BIOTRONIK announced today the commercial launch of Solia S ProMRI®, with a 5.6 French lead body, the smallest MR conditional pacing lead available...

BIOTRONIK Announces CE Mark for Magmaris, the First Clinically Proven Bioresorbable Magnesium Scaffold

, Medical Technology

BIOTRONIK announced today that the Magmaris bioresorbable scaffold has received CE mark approval. The first clinically proven magnesium scaffold,...

BIOTRONIK Wins Cardiostim Innovation Award for Best Practice Improvement with MRI AutoDetect Feature

, Medical Technology

BIOTRONIK has won the Cardiostim Innovation Award in the category “Best Practice Improvement” for its MRI AutoDetect feature. The company’s Ilivia...

Cardiostim 2016: Growing Importance of Remote Monitoring and Potential for New Heart Monitor Indications Detailed at Scientific Session

, Medical Technology

BIOTRONIK Home Monitoring® received strong endorsements during the Cardiostim scientific session “Improving Patient Outcomes in Arrhythmia Management.” Every...

Physicians Present at Cardiostim Conference's All-Women Panel: Hot Topics in CRM

, Medical Technology

Physicians presented original research and real-world clinical evidence at a symposium organized by the EPIC Alliance, an initiative to promote...

Bioresorbierbares Gefäßgerüst aus Magnesium stellt Langzeitsicherheit in BIOSOLVE-II Studie unter Beweis

, Medical Technology

Im Rahmen der Jahrestagung der Österreichischen Kardiologischen Gesellschaft (ÖKG) in Salzburg hat BIOTRONIK neueste Erkenntnisse zur Sicherheit...

Compelling Efficacy and Safety Data for Orsiro Hybrid Drug-Eluting Stent Presented during EuroPCR Hotline Session

, Medical Technology

BIOTRONIK today announced results establishing non-inferiority of the Orsiro hybrid drug-eluting stent (DES) to the Resolute Integrity DES were...

BIOTRONIK Launches CardioMessenger Smart Portable Device For Pacemaker and ICD Patients

, Medical Technology

BIOTRONIK, a global leader in cardio- and endovascular medical technology, today announced the launch of CardioMessenger Smart in the United...

EuroPCR 2016: Pantera Lux Drug-Coated Balloon Proves Non-Inferior to Drug-Eluting Stent

, Research / Development

Randomized Controlled Trial Establishes Pantera Lux as a Viable Alternative to a Latest Generation Limus Eluting Stent in Treatment of In-Stent...

EuroPCR 2016:世界初のマグネシウム製生体吸収性スキャフォールドであるマグマリス(Magmaris*)が、BIOSOLVE-II試験において長期の安全性を示した

, Research / Development

2016年5月17日–フランス(パリ)、­スイス(ビュラハ) バイオトロニック社­は、本日、EuroPCR 2016(欧州の学会)のホットラインセッ­ションにおいて、BIOSOLVE-II試験の12か月までの結果を発表しまし­た。 本試験によって、世界初となる、シ­ロリマス薬剤溶出型のマグネシウム製生体吸­収性スキャフォールド[製品名:マグマリス­*]の安全性と有効性を証明しました。この­試験は、前向き国際First-in-human試験であり、12か月までの結果­は、 The...

EuroPCR 2016: Magmaris*, the First Clinically Proven Bioresorbable Magnesium Scaffold, Shows Long-Term Safety in BIOSOLVE-II Trial

, Medical Technology

BIOTRONIK today presented 12 month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016. The study established the safety...

BIOSTEMI Trial to Establish Orsiro's Enhanced Efficacy and Safety in Challenging Indication

, Medical Technology

BIOTRONIK announced today the first patient enrolment in the BIOSTEMI trial. The randomized, controlled superiority trial is the first to directly...


Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Woermannkehre 1
D - 12359 Berlin


Frau Manuela Schildwächter

Communications & PR Manager

Telefon +49 (30) 689051414

Frau Teresa McGowan

Freelance Communications & PR Manager

Telefon +49 (30) 68905-1416
Fax +49 (30) 6890596-1466

alle Ansprechpartner

The specified publisher (see company information at right) is responsible for the above press release. Normally, this is also the author of the press releases, as well as attached image, audio or information material. The unn | UNITED NEWS NETWORK GmbH accepts no responsibility for accuracy, or completeness of the displayed press release. Also, regarding transmission errors or other disorders shall be liable only in cases of willful intent or gross negligence.
The use of archived information for personal and journalistic use is normally free of charge. Please clarify any copyright issues regarding further use of material with the specified publisher. Upon publication, please send a courtesy copy to service@pressebox.de.
A systematic storage of these data as well as the use of a part or the whole of this data base is subject to written appoval by the unn | UNITED NEWS NETWORK GmbH.

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.